申请人:Abbott Laboratories
公开号:US04435422A1
公开(公告)日:1984-03-06
Described are compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 independently of one another denote hydrogen or loweralkyl; A is CO, CH.sub.2, O, S, SO or CHOH; X is hydrogen, halo, loweralkyl, or --CH.sub.2 NR.sub.1 R.sub.2 wherein R.sub.1 and R.sub.2 are as defined above; W is COOR wherein R is hydrogen or alkyl of 1-10 carbon atoms, CH.sub.2 OH, CONR.sub.1 R.sub.2 or CH.sub.2 NR.sub.1 R.sub.2 wherein R.sub.1 and R.sub.2 are as defined above; Z.sub.1 and Z.sub.2 independently of one another denote hydrogen, halo or loweralkyl; and pharmaceutically acceptable salts thereof. The compounds are effective as diuretic agents.
描述了以下化合物的结构式: ##STR1## 其中R.sub.1和R.sub.2独立地表示氢或低碳基;A为CO,CH.sub.2,O,S,SO或CHOH;X为氢,卤素,低碳基,或--CH.sub.2 NR.sub.1 R.sub.2,其中R.sub.1和R.sub.2如上所定义;W为COOR,其中R为氢或1-10碳原子的烷基,CH.sub.2 OH,CONR.sub.1 R.sub.2或CH.sub.2 NR.sub.1 R.sub.2,其中R.sub.1和R.sub.2如上所定义;Z.sub.1和Z.sub.2独立地表示氢,卤素或低碳基;以及其药学上可接受的盐。这些化合物作为利尿剂具有有效性。